Margot A Lazow

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Margot A. Lazow

Biography

Margot Lazow, MD, is a pediatric neuro-oncologist in the brain tumor program at Nationwide Children’s Hospital and an assistant professor at The Ohio State University Wexner Medical Center. She completed pediatric hematology/oncology and neuro-oncology fellowships at Cincinnati Children’s Hospital, where she also earned a Masters in Clinical and Translational Research. Dr. Lazow is interested in clinical trial development and clinical research, with a focus on uncovering the molecular underpinnings of difficult-to-treat pediatric brain/spine tumors and translating findings into early phase trials using genomically-targeted agents.

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Neuro-Oncology

Physician Team

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Research

Publications

                  Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;  

                


                  Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;  

                


                  Lazow MA, Nievelstein MT, Lane A, Bandopadhayhay P, DeWire-Schottmiller M, Fouladi M, Glod JW, Greiner RJ, Hoffman LM, Hummel TR, Kilburn L, Leary S, Minturn JE, Packer R, Ziegler DS, Chaney B, Black K, de Blank P, Leach JL. Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. Neuro Oncol. 2022 Feb 11;  

                


                  DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.

                


                  Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.

                


                  Lazow MA, Fuller C, DeWire M, Lane A, Bandopadhayay P, Bartels U, Bouffet E, Cheng S, Cohen KJ, Cooney TM, Coven SL, Dholaria H, Diez B, Dorris K, El-Ayadi M, El-Sheikh A, Fisher PG, Fonseca A, Lombardi MG, Greiner RJ, Goldman S, Gottardo N, Gururangan S, Hansford JR, Hassall T, Hawkins C, Kilburn L, Koschmann C, Leary SE, Ma J, Minturn JE, Monje-Deisseroth M, Packer R, Samson Y, Sandler ES, Sevlever G, Tinkle CL, Tsui K, Wagner LM, Zaghloul M, Ziegler DS, Chaney B, Black K, Asher A, Drissi R, Fouladi M, Jones BV, Leach JL. Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry. Neuro Oncol. 2021 Oct 20;  

                


                  Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.

                


                  Lazow MA, Leach JL, Trout AT, Breneman JC, Fouladi M, Fuller C. Extraneural Metastases of Diffuse Midline Glioma, H3 K27M-Mutant at Diagnosis: Case Report, Review of the Literature, and Identifying Targetable Alterations. J Pediatr Hematol Oncol. 2021 May 11;  

                


                  Zhu X, Lazow MA, Schafer A, Bartlett A, Senthil Kumar S, Mishra DK, Dexheimer P, DeWire M, Fuller C, Leach JL, Fouladi M, Drissi R. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Acta Neuropathol Commun. 2021 Jan 11; 9: 14.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 07/19/2021

Board Certifications

Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2021

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/11/2021

Residency

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2018

Medical School

Vanderbilt University School of Medicine

Date Completed: 05/08/2015

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Margot A. Lazow

Biography

Margot Lazow, MD, is a pediatric neuro-oncologist in the brain tumor program at Nationwide Children’s Hospital and an assistant professor at The Ohio State University Wexner Medical Center. She completed pediatric hematology/oncology and neuro-oncology fellowships at Cincinnati Children’s Hospital, where she also earned a Masters in Clinical and Translational Research. Dr. Lazow is interested in clinical trial development and clinical research, with a focus on uncovering the molecular underpinnings of difficult-to-treat pediatric brain/spine tumors and translating findings into early phase trials using genomically-targeted agents.

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Neuro-Oncology

Physician Team

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Research

Publications

                  Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;  

                


                  Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;  

                


                  Lazow MA, Nievelstein MT, Lane A, Bandopadhayhay P, DeWire-Schottmiller M, Fouladi M, Glod JW, Greiner RJ, Hoffman LM, Hummel TR, Kilburn L, Leary S, Minturn JE, Packer R, Ziegler DS, Chaney B, Black K, de Blank P, Leach JL. Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. Neuro Oncol. 2022 Feb 11;  

                


                  DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.

                


                  Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.

                


                  Lazow MA, Fuller C, DeWire M, Lane A, Bandopadhayay P, Bartels U, Bouffet E, Cheng S, Cohen KJ, Cooney TM, Coven SL, Dholaria H, Diez B, Dorris K, El-Ayadi M, El-Sheikh A, Fisher PG, Fonseca A, Lombardi MG, Greiner RJ, Goldman S, Gottardo N, Gururangan S, Hansford JR, Hassall T, Hawkins C, Kilburn L, Koschmann C, Leary SE, Ma J, Minturn JE, Monje-Deisseroth M, Packer R, Samson Y, Sandler ES, Sevlever G, Tinkle CL, Tsui K, Wagner LM, Zaghloul M, Ziegler DS, Chaney B, Black K, Asher A, Drissi R, Fouladi M, Jones BV, Leach JL. Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry. Neuro Oncol. 2021 Oct 20;  

                


                  Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.

                


                  Lazow MA, Leach JL, Trout AT, Breneman JC, Fouladi M, Fuller C. Extraneural Metastases of Diffuse Midline Glioma, H3 K27M-Mutant at Diagnosis: Case Report, Review of the Literature, and Identifying Targetable Alterations. J Pediatr Hematol Oncol. 2021 May 11;  

                


                  Zhu X, Lazow MA, Schafer A, Bartlett A, Senthil Kumar S, Mishra DK, Dexheimer P, DeWire M, Fuller C, Leach JL, Fouladi M, Drissi R. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Acta Neuropathol Commun. 2021 Jan 11; 9: 14.

View More Publications

Education

Date of Appointment at Nationwide Children’s Hospital: 07/19/2021

Board Certifications

Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2021

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/11/2021

Residency

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2018

Medical School

Vanderbilt University School of Medicine

Date Completed: 05/08/2015

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Margot A. Lazow

Contact Information

• Call us at:
• (614) 722-3550
• Fax us at:
• (614) 722-3369
• PediatricsHematology & Oncology700 Children’s DrColumbus, OH 43205 (map)

Learn more about Margot A. Lazow

Biography

Margot Lazow, MD, is a pediatric neuro-oncologist in the brain tumor program at Nationwide Children’s Hospital and an assistant professor at The Ohio State University Wexner Medical Center. She completed pediatric hematology/oncology and neuro-oncology fellowships at Cincinnati Children’s Hospital, where she also earned a Masters in Clinical and Translational Research. Dr. Lazow is interested in clinical trial development and clinical research, with a focus on uncovering the molecular underpinnings of difficult-to-treat pediatric brain/spine tumors and translating findings into early phase trials using genomically-targeted agents.

Biography

Margot Lazow, MD, is a pediatric neuro-oncologist in the brain tumor program at Nationwide Children’s Hospital and an assistant professor at The Ohio State University Wexner Medical Center. She completed pediatric hematology/oncology and neuro-oncology fellowships at Cincinnati Children’s Hospital, where she also earned a Masters in Clinical and Translational Research. Dr. Lazow is interested in clinical trial development and clinical research, with a focus on uncovering the molecular underpinnings of difficult-to-treat pediatric brain/spine tumors and translating findings into early phase trials using genomically-targeted agents.

Biography

Margot Lazow, MD, is a pediatric neuro-oncologist in the brain tumor program at Nationwide Children’s Hospital and an assistant professor at The Ohio State University Wexner Medical Center. She completed pediatric hematology/oncology and neuro-oncology fellowships at Cincinnati Children’s Hospital, where she also earned a Masters in Clinical and Translational Research. Dr. Lazow is interested in clinical trial development and clinical research, with a focus on uncovering the molecular underpinnings of difficult-to-treat pediatric brain/spine tumors and translating findings into early phase trials using genomically-targeted agents.

Margot Lazow, MD, is a pediatric neuro-oncologist in the brain tumor program at Nationwide Children’s Hospital and an assistant professor at The Ohio State University Wexner Medical Center. She completed pediatric hematology/oncology and neuro-oncology fellowships at Cincinnati Children’s Hospital, where she also earned a Masters in Clinical and Translational Research. Dr. Lazow is interested in clinical trial development and clinical research, with a focus on uncovering the molecular underpinnings of difficult-to-treat pediatric brain/spine tumors and translating findings into early phase trials using genomically-targeted agents.

Margot Lazow, MD, is a pediatric neuro-oncologist in the brain tumor program at Nationwide Children’s Hospital and an assistant professor at The Ohio State University Wexner Medical Center. She completed pediatric hematology/oncology and neuro-oncology fellowships at Cincinnati Children’s Hospital, where she also earned a Masters in Clinical and Translational Research. Dr. Lazow is interested in clinical trial development and clinical research, with a focus on uncovering the molecular underpinnings of difficult-to-treat pediatric brain/spine tumors and translating findings into early phase trials using genomically-targeted agents.

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Neuro-Oncology

Physician Team

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Neuro-Oncology

Physician Team

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Academic and Clinical Areas

Hematology/Oncology & BMT

Physician Team

Neuro-Oncology

Physician Team

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

Hematology/Oncology & BMT

Physician Team

Neuro-Oncology

Physician Team

Primary Department

Pediatrics

Primary Section

Hematology & Oncology

• Hematology/Oncology & BMT
• Physician Team
• Neuro-Oncology
• Physician Team
• Primary Department
• Pediatrics
• Primary Section
• Hematology & Oncology

Research

Publications

                  Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;  

                


                  Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;  

                


                  Lazow MA, Nievelstein MT, Lane A, Bandopadhayhay P, DeWire-Schottmiller M, Fouladi M, Glod JW, Greiner RJ, Hoffman LM, Hummel TR, Kilburn L, Leary S, Minturn JE, Packer R, Ziegler DS, Chaney B, Black K, de Blank P, Leach JL. Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. Neuro Oncol. 2022 Feb 11;  

                


                  DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.

                


                  Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.

                


                  Lazow MA, Fuller C, DeWire M, Lane A, Bandopadhayay P, Bartels U, Bouffet E, Cheng S, Cohen KJ, Cooney TM, Coven SL, Dholaria H, Diez B, Dorris K, El-Ayadi M, El-Sheikh A, Fisher PG, Fonseca A, Lombardi MG, Greiner RJ, Goldman S, Gottardo N, Gururangan S, Hansford JR, Hassall T, Hawkins C, Kilburn L, Koschmann C, Leary SE, Ma J, Minturn JE, Monje-Deisseroth M, Packer R, Samson Y, Sandler ES, Sevlever G, Tinkle CL, Tsui K, Wagner LM, Zaghloul M, Ziegler DS, Chaney B, Black K, Asher A, Drissi R, Fouladi M, Jones BV, Leach JL. Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry. Neuro Oncol. 2021 Oct 20;  

                


                  Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.

                


                  Lazow MA, Leach JL, Trout AT, Breneman JC, Fouladi M, Fuller C. Extraneural Metastases of Diffuse Midline Glioma, H3 K27M-Mutant at Diagnosis: Case Report, Review of the Literature, and Identifying Targetable Alterations. J Pediatr Hematol Oncol. 2021 May 11;  

                


                  Zhu X, Lazow MA, Schafer A, Bartlett A, Senthil Kumar S, Mishra DK, Dexheimer P, DeWire M, Fuller C, Leach JL, Fouladi M, Drissi R. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Acta Neuropathol Commun. 2021 Jan 11; 9: 14.

View More Publications

Research

Publications

                  Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;  

                


                  Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;  

                


                  Lazow MA, Nievelstein MT, Lane A, Bandopadhayhay P, DeWire-Schottmiller M, Fouladi M, Glod JW, Greiner RJ, Hoffman LM, Hummel TR, Kilburn L, Leary S, Minturn JE, Packer R, Ziegler DS, Chaney B, Black K, de Blank P, Leach JL. Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. Neuro Oncol. 2022 Feb 11;  

                


                  DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.

                


                  Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.

                


                  Lazow MA, Fuller C, DeWire M, Lane A, Bandopadhayay P, Bartels U, Bouffet E, Cheng S, Cohen KJ, Cooney TM, Coven SL, Dholaria H, Diez B, Dorris K, El-Ayadi M, El-Sheikh A, Fisher PG, Fonseca A, Lombardi MG, Greiner RJ, Goldman S, Gottardo N, Gururangan S, Hansford JR, Hassall T, Hawkins C, Kilburn L, Koschmann C, Leary SE, Ma J, Minturn JE, Monje-Deisseroth M, Packer R, Samson Y, Sandler ES, Sevlever G, Tinkle CL, Tsui K, Wagner LM, Zaghloul M, Ziegler DS, Chaney B, Black K, Asher A, Drissi R, Fouladi M, Jones BV, Leach JL. Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry. Neuro Oncol. 2021 Oct 20;  

                


                  Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.

                


                  Lazow MA, Leach JL, Trout AT, Breneman JC, Fouladi M, Fuller C. Extraneural Metastases of Diffuse Midline Glioma, H3 K27M-Mutant at Diagnosis: Case Report, Review of the Literature, and Identifying Targetable Alterations. J Pediatr Hematol Oncol. 2021 May 11;  

                


                  Zhu X, Lazow MA, Schafer A, Bartlett A, Senthil Kumar S, Mishra DK, Dexheimer P, DeWire M, Fuller C, Leach JL, Fouladi M, Drissi R. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Acta Neuropathol Commun. 2021 Jan 11; 9: 14.

View More Publications

Research

Publications

                  Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;  

                


                  Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;  

                


                  Lazow MA, Nievelstein MT, Lane A, Bandopadhayhay P, DeWire-Schottmiller M, Fouladi M, Glod JW, Greiner RJ, Hoffman LM, Hummel TR, Kilburn L, Leary S, Minturn JE, Packer R, Ziegler DS, Chaney B, Black K, de Blank P, Leach JL. Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. Neuro Oncol. 2022 Feb 11;  

                


                  DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.

                


                  Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.

                


                  Lazow MA, Fuller C, DeWire M, Lane A, Bandopadhayay P, Bartels U, Bouffet E, Cheng S, Cohen KJ, Cooney TM, Coven SL, Dholaria H, Diez B, Dorris K, El-Ayadi M, El-Sheikh A, Fisher PG, Fonseca A, Lombardi MG, Greiner RJ, Goldman S, Gottardo N, Gururangan S, Hansford JR, Hassall T, Hawkins C, Kilburn L, Koschmann C, Leary SE, Ma J, Minturn JE, Monje-Deisseroth M, Packer R, Samson Y, Sandler ES, Sevlever G, Tinkle CL, Tsui K, Wagner LM, Zaghloul M, Ziegler DS, Chaney B, Black K, Asher A, Drissi R, Fouladi M, Jones BV, Leach JL. Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry. Neuro Oncol. 2021 Oct 20;  

                


                  Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.

                


                  Lazow MA, Leach JL, Trout AT, Breneman JC, Fouladi M, Fuller C. Extraneural Metastases of Diffuse Midline Glioma, H3 K27M-Mutant at Diagnosis: Case Report, Review of the Literature, and Identifying Targetable Alterations. J Pediatr Hematol Oncol. 2021 May 11;  

                


                  Zhu X, Lazow MA, Schafer A, Bartlett A, Senthil Kumar S, Mishra DK, Dexheimer P, DeWire M, Fuller C, Leach JL, Fouladi M, Drissi R. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Acta Neuropathol Commun. 2021 Jan 11; 9: 14.

View More Publications

Publications

                  Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;  

                


                  Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;  

                


                  Lazow MA, Nievelstein MT, Lane A, Bandopadhayhay P, DeWire-Schottmiller M, Fouladi M, Glod JW, Greiner RJ, Hoffman LM, Hummel TR, Kilburn L, Leary S, Minturn JE, Packer R, Ziegler DS, Chaney B, Black K, de Blank P, Leach JL. Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. Neuro Oncol. 2022 Feb 11;  

                


                  DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.

                


                  Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.

                


                  Lazow MA, Fuller C, DeWire M, Lane A, Bandopadhayay P, Bartels U, Bouffet E, Cheng S, Cohen KJ, Cooney TM, Coven SL, Dholaria H, Diez B, Dorris K, El-Ayadi M, El-Sheikh A, Fisher PG, Fonseca A, Lombardi MG, Greiner RJ, Goldman S, Gottardo N, Gururangan S, Hansford JR, Hassall T, Hawkins C, Kilburn L, Koschmann C, Leary SE, Ma J, Minturn JE, Monje-Deisseroth M, Packer R, Samson Y, Sandler ES, Sevlever G, Tinkle CL, Tsui K, Wagner LM, Zaghloul M, Ziegler DS, Chaney B, Black K, Asher A, Drissi R, Fouladi M, Jones BV, Leach JL. Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry. Neuro Oncol. 2021 Oct 20;  

                


                  Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.

                


                  Lazow MA, Leach JL, Trout AT, Breneman JC, Fouladi M, Fuller C. Extraneural Metastases of Diffuse Midline Glioma, H3 K27M-Mutant at Diagnosis: Case Report, Review of the Literature, and Identifying Targetable Alterations. J Pediatr Hematol Oncol. 2021 May 11;  

                


                  Zhu X, Lazow MA, Schafer A, Bartlett A, Senthil Kumar S, Mishra DK, Dexheimer P, DeWire M, Fuller C, Leach JL, Fouladi M, Drissi R. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Acta Neuropathol Commun. 2021 Jan 11; 9: 14.

View More Publications

                  Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;  

                


                  Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;  

                


                  Lazow MA, Nievelstein MT, Lane A, Bandopadhayhay P, DeWire-Schottmiller M, Fouladi M, Glod JW, Greiner RJ, Hoffman LM, Hummel TR, Kilburn L, Leary S, Minturn JE, Packer R, Ziegler DS, Chaney B, Black K, de Blank P, Leach JL. Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. Neuro Oncol. 2022 Feb 11;  

                


                  DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.

                


                  Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.

                


                  Lazow MA, Fuller C, DeWire M, Lane A, Bandopadhayay P, Bartels U, Bouffet E, Cheng S, Cohen KJ, Cooney TM, Coven SL, Dholaria H, Diez B, Dorris K, El-Ayadi M, El-Sheikh A, Fisher PG, Fonseca A, Lombardi MG, Greiner RJ, Goldman S, Gottardo N, Gururangan S, Hansford JR, Hassall T, Hawkins C, Kilburn L, Koschmann C, Leary SE, Ma J, Minturn JE, Monje-Deisseroth M, Packer R, Samson Y, Sandler ES, Sevlever G, Tinkle CL, Tsui K, Wagner LM, Zaghloul M, Ziegler DS, Chaney B, Black K, Asher A, Drissi R, Fouladi M, Jones BV, Leach JL. Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry. Neuro Oncol. 2021 Oct 20;  

                


                  Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.

                


                  Lazow MA, Leach JL, Trout AT, Breneman JC, Fouladi M, Fuller C. Extraneural Metastases of Diffuse Midline Glioma, H3 K27M-Mutant at Diagnosis: Case Report, Review of the Literature, and Identifying Targetable Alterations. J Pediatr Hematol Oncol. 2021 May 11;  

                


                  Zhu X, Lazow MA, Schafer A, Bartlett A, Senthil Kumar S, Mishra DK, Dexheimer P, DeWire M, Fuller C, Leach JL, Fouladi M, Drissi R. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Acta Neuropathol Commun. 2021 Jan 11; 9: 14.

View More Publications

• Lazow MA, Palmer JD, Fouladi M, Salloum R. Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management. Neurotherapeutics. 2022 Jul 20;
• Lazow MA, Salloum R, Pressey JG. Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas. J Adolesc Young Adult Oncol. 2022 Jun 8;
• Lazow MA, Nievelstein MT, Lane A, Bandopadhayhay P, DeWire-Schottmiller M, Fouladi M, Glod JW, Greiner RJ, Hoffman LM, Hummel TR, Kilburn L, Leary S, Minturn JE, Packer R, Ziegler DS, Chaney B, Black K, de Blank P, Leach JL. Volumetric endpoints in diffuse intrinsic pontine glioma: comparison to cross-sectional measures and outcome correlations in the International DIPG/DMG Registry. Neuro Oncol. 2022 Feb 11;
• DeWire M, Lazow M, Campagne O, Leach J, Fuller C, Senthil Kumar S, Stanek J, de Blank P, Hummel TR, Pillay-Smiley N, Salloum R, Stevenson CB, Baxter P, Gass D, Goldman S, Leary SES, Carle A, Mikael L, Crabtree D, Chaney B, Lane A, Drissi R, Stewart CF, Fouladi M. Phase I study of ribociclib and everolimus in children with newly diagnosed DIPG and high-grade glioma: A CONNECT pediatric neuro-oncology consortium report. Neurooncol Adv. 2022 Jan-Dec; 4: vdac055.
• Lazow MA, Fuller C, Trout AT, Stanek JR, Reuss J, Turpin BK, Szabo S, Salloum R. Immunohistochemical assessment and clinical, histopathologic, and molecular correlates of membranous somatostatin type-2A receptor expression in high-risk pediatric central nervous system tumors. Front Oncol. 2022; 12: 996489.
• Lazow MA, Fuller C, DeWire M, Lane A, Bandopadhayay P, Bartels U, Bouffet E, Cheng S, Cohen KJ, Cooney TM, Coven SL, Dholaria H, Diez B, Dorris K, El-Ayadi M, El-Sheikh A, Fisher PG, Fonseca A, Lombardi MG, Greiner RJ, Goldman S, Gottardo N, Gururangan S, Hansford JR, Hassall T, Hawkins C, Kilburn L, Koschmann C, Leary SE, Ma J, Minturn JE, Monje-Deisseroth M, Packer R, Samson Y, Sandler ES, Sevlever G, Tinkle CL, Tsui K, Wagner LM, Zaghloul M, Ziegler DS, Chaney B, Black K, Asher A, Drissi R, Fouladi M, Jones BV, Leach JL. Accuracy of Central Neuro-Imaging Review of DIPG Compared with Histopathology in the International DIPG Registry. Neuro Oncol. 2021 Oct 20;
• Lazow MA, Lawson SA, Salloum R, Hummel TR, Pillay Smiley N, DeWire-Schottmiller MD, Fouladi M, de Blank P. Trametinib-associated Hyponatremia in a Child With Low-grade Glioma is Not Seen Following Treatment With Alternative MEK Inhibitor. J Pediatr Hematol Oncol. 2021 May 1; 43: e550-e553.
• Lazow MA, Leach JL, Trout AT, Breneman JC, Fouladi M, Fuller C. Extraneural Metastases of Diffuse Midline Glioma, H3 K27M-Mutant at Diagnosis: Case Report, Review of the Literature, and Identifying Targetable Alterations. J Pediatr Hematol Oncol. 2021 May 11;
• Zhu X, Lazow MA, Schafer A, Bartlett A, Senthil Kumar S, Mishra DK, Dexheimer P, DeWire M, Fuller C, Leach JL, Fouladi M, Drissi R. A pilot radiogenomic study of DIPG reveals distinct subgroups with unique clinical trajectories and therapeutic targets. Acta Neuropathol Commun. 2021 Jan 11; 9: 14.

Education

Date of Appointment at Nationwide Children’s Hospital: 07/19/2021

Board Certifications

Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2021

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/11/2021

Residency

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2018

Medical School

Vanderbilt University School of Medicine

Date Completed: 05/08/2015

Education

Date of Appointment at Nationwide Children’s Hospital: 07/19/2021

Board Certifications

Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2021

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/11/2021

Residency

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2018

Medical School

Vanderbilt University School of Medicine

Date Completed: 05/08/2015

Education

Date of Appointment at Nationwide Children’s Hospital: 07/19/2021

Board Certifications

Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2021

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/11/2021

Residency

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2018

Medical School

Vanderbilt University School of Medicine

Date Completed: 05/08/2015

Date of Appointment at Nationwide Children’s Hospital: 07/19/2021

Board Certifications

Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2021

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/11/2021

Residency

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2018

Medical School

Vanderbilt University School of Medicine

Date Completed: 05/08/2015

Date of Appointment at Nationwide Children’s Hospital: 07/19/2021

Board Certifications

Pediatrics

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2021

Fellowship

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/11/2021

Residency

Cincinnati Children’s Hospital Medical Center

Date Completed: 06/30/2018

Medical School

Vanderbilt University School of Medicine

Date Completed: 05/08/2015

• Pediatrics

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Contact Information

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Pediatrics

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

Call us at: (614) 722-3550

Fax us at: (614) 722-3369

                    Hematology & Oncology700 Children's DrColumbus, OH 43205 (map)

• Call us at:
• (614) 722-3550
• Fax us at:
• (614) 722-3369
• Hematology & Oncology700 Children’s DrColumbus, OH 43205 (map)